Skip to content
Screener

Tandem Diabetes Care TNDM Common stock, par value (in dollars per share)

Common stock, par value (in dollars per share) at other companies

Insulet logo
InsuletPODD
$00.0%
Embecta Corp. logo
Embecta Corp.EMBC
$0.010.0%
KORU Medical Systems logo
KORU Medical SystemsKRMD
$0.010.0%
Medtronic logo
MedtronicMDT
InfuSystem Holdings logo
InfuSystem HoldingsINFU
TriSalus Life Sciences, Inc. logo
TriSalus Life Sciences, Inc.TLSI

Other financials

Income statement

See full
Revenue$254.6M+5.8%
Gross profit$144.8M+15.0%
Operating income-$13.8M+73.4%
Net income-$21.2M+59.6%
EPS (diluted)-$0.31+60.3%

Balance sheet

See full
Cash & equivalents$62.8M-2.0%
Total debt$739.3M+64.6%
Total equity$130.4M-2.2%
Total assets$1.2B+31.8%

Cash flow

See full
Operating cash flow-$34.6M-265%
CapEx$4.1M-34.7%
Free cash flow-$38.7M-146%

Valuation

See full
Market cap$1.56B+132%
Enterprise value$2.23B+112%
P/S1.5×+0.8×

Profitability

See full
Gross margin56%+3.5pp
Operating margin-4.4%-1.9pp
Net margin-6.1%-2.5pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-48%-17.5pp
Debt / equity5.7×+2.3×
Current ratio3.2×+0.7×

Where this comes from

Reported directly by Tandem Diabetes Care in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001438133-26-000125
AssetsJune 30, 2026 / (Unaudited)December 31, 2025 / (Note 1)
Total liabilities1,023,814725,942
Commitments and contingencies (Note 14)
Stockholders’ equity:
Common stock, $0.001 par value; 200,000 shares authorized, 69,540 and 68,291 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively7068
Additional paid-in capital1,418,0111,402,044
Accumulated other comprehensive income6,4035,593
Accumulated deficit(1,294,096)(1,252,535)
Total stockholders’ equity130,388155,170

Item 1. Financial Statements.

FAQ

What is Tandem Diabetes Care's common stock, par value (in dollars per share)?
Tandem Diabetes Care (TNDM) reported common stock, par value (in dollars per share) of $0 in Q2 2026.
How has Tandem Diabetes Care's common stock, par value (in dollars per share) changed year-over-year?
Tandem Diabetes Care's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
What is the long-term trend for Tandem Diabetes Care's common stock, par value (in dollars per share)?
Over 5 years (2020 to 2025), Tandem Diabetes Care's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.
What does common stock, par value (in dollars per share) mean?
Common stock, par value (in dollars per share)

Ask your AI about Tandem Diabetes Care's common stock, par value (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude